Patient-Centric Mission. Asset-Centric Approach. We’re pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake disorders. Patient-Centric Mission. Asset-Centric Approach. We’re pursuing SerpinPC as a potential novel subcutaneous treatment for hemophilia B patients with potential expansion into other bleeding disorders. Patient-Centric Mission. Asset-Centric Approach. We’re pursuing our LockBody® Technology Platform with […]
